Updated:
InnoVision Capital
InnoVision Capital is a private equity firm founded in 2016 in Chaoyang District, China. It manages investment funds focused on green energy, climate impact,...
InnoVision Capital
InnoVision Capital is a private equity firm founded in 2016 in Chaoyang District, China. It manages investment funds focused on green energy, climate impact, ESG, internet services, and other industries. The firm has made 13 investments, including a Series A - IV investment in iCamuno Biotherapeutics on March 09, 2026.
General information
Firm type
Private Equity
Year founded
2016
Location
Region
Asia
Country
China
City
Beijing
Corporate office
Beijing, China
Sector focus
Frequently asked questions
What investment stages does InnoVision Capital target?
InnoVision Capital spans early-stage venture, growth, expansion, late-stage, pre-IPO, and buyout rounds. The firm does not delineate separate fund families for each stage, instead operating a single mandate that holds positions across the corporate lifecycle. This blurs the line between venture and buyout, a structural choice that reduces external financing risk for portfolio companies at inflection points.
How does InnoVision Capital source deals?
Specific sourcing mechanisms are not publicly detailed. For an RMB-denominated multi-stage manager in Beijing, probable channels include provincial government relationships, state-owned enterprise carve-outs, and founder networks built during prior investment cycles in enterprise technology and industrial tech. The firm's ability to hold through pre-IPO makes it a natural partner for companies that value patient capital over speed to exit.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: